Efficacy and safety of tau-aggregation inhibitor therapy in patients with mild or moderate Alzheimer's disease: a randomised, controlled, double-blind, parallel-arm, phase 3 trial
Gauthier, Serge, Prof, Feldman, Howard H, Prof, Schneider, Lon S, Prof, Wilcock, Gordon K, Prof, Frisoni, Giovanni B, Prof, Hardlund, Jiri H, MD, Moebius, Hans J, MD, Bentham, Peter, MBChB, Kook, Karin A, PhD, Wischik, Damon J, PhD, Schelter, Bjoern O, Prof, Davis, Charles S, PhD, Staff, Roger T, PhD, Bracoud, Luc, MSc, Shamsi, Kohkan, MD, Storey, John M D, Prof, Harrington, Charles R, PhD, Wischik, Claude M, Prof
Published in The Lancet (British edition) (10.12.2016)
Published in The Lancet (British edition) (10.12.2016)
Get full text
Journal Article